Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter?
Clinical trials for personalized glioblastoma radiotherapy: Markers for efficacy and late toxicity but often delayed treatment – Does that matter?
Lattermann, A.; Baumann, M.; Krause, M.
-
Radiotherapy and Oncology 118(2016)1, 211-213
DOI: 10.1016/j.radonc.2016.02.001
Cited 3 times in Scopus
Permalink: https://www.hzdr.de/publications/Publ-25126
Publ.-Id: 25126